Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and Graft-Versus-Host Disease

pomalidomide has been researched along with Graft-Versus-Host Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Baird, K; Berger, A; Cao, L; Comis, LE; Cowen, EW; Curtis, LM; Figg, WD; Gale, RP; Hakim, FT; Holtzman, NG; Joe, GO; Kuzmina, ZJ; Mays, JW; Mitchell, SA; Ostojic, A; Parsons-Wandell, L; Pavletic, SZ; Peer, CJ; Pirsl, F; Pusic, I; Rose, JJ; Venzon, DJ1
Lazaryan, A1
Elkinson, S; McCormack, PL1
Bauer, S; DiPersio, JF; Gale, RP; McFarland, K; Pavletic, SZ; Pusic, I; Rettig, MP1
Gahrton, G1

Reviews

2 review(s) available for pomalidomide and Graft-Versus-Host Disease

ArticleYear
Pomalidomide: first global approval.
    Drugs, 2013, Volume: 73, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Clinical Trials as Topic; Drug Approval; Graft vs Host Disease; Humans; Multiple Myeloma; Thalidomide

2013
Progress in allogeneic transplantation for multiple myeloma.
    European journal of haematology, 2010, Volume: 85, Issue:4

    Topics: Antineoplastic Agents; Cyclophosphamide; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Killer Cells, Natural; Lymphocyte Transfusion; Multiple Myeloma; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation

2010

Trials

2 trial(s) available for pomalidomide and Graft-Versus-Host Disease

ArticleYear
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
    Blood, 2021, 02-18, Volume: 137, Issue:7

    Topics: Adolescent; Adult; Aged; Allografts; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance; Fatigue; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Infections; Joints; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Middle Aged; Quality of Life; Salvage Therapy; Skin; Thalidomide; Young Adult

2021
Phase-1/-2 study of pomalidomide in chronic GvHD.
    Bone marrow transplantation, 2016, Volume: 51, Issue:4

    Topics: Adult; Chronic Disease; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Pilot Projects; Thalidomide

2016

Other Studies

1 other study(ies) available for pomalidomide and Graft-Versus-Host Disease

ArticleYear
New is forgotten old: IMiDs against chronic GVHD.
    Blood, 2021, 02-18, Volume: 137, Issue:7

    Topics: Graft vs Host Disease; Humans; Immunologic Factors; Thalidomide

2021